BERMAN DENNIS N

CIK 00012738583 companiesWILMINGTON, DE

SEC Profile

Transactions

Companies

Filings

CIK

0001273858

Recent Transactions

31 trades

Exercise/Conversion
Inhibikase Therapeutics, Inc.$IKT
Common Stock
2026-07-30$1.26/sh+21,854→ 21,854 total
Exercise/Conversion
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2026-07-30−21,854→ 0 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2026-06-26+155,000→ 155,000 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-06-30+108,176→ 108,176 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-02-14+39,620→ 39,620 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21+30,000→ 30,000 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21+6,667→ 6,667 total
Disposition to Issuer
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21−6,667→ 0 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21+6,667→ 6,667 total
Disposition to Issuer
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21−30,000→ 0 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21+30,000→ 30,000 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21+21,854→ 21,854 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21+3,780→ 3,780 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21+6,667→ 6,667 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21+6,667→ 6,667 total
Disposition to Issuer
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21−21,854→ 0 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21+21,854→ 21,854 total
Disposition to Issuer
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21−1,138→ 0 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21+1,138→ 1,138 total
Disposition to Issuer
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21−3,780→ 0 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21+3,780→ 3,780 total
Disposition to Issuer
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21−6,667→ 0 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-03+344,452→ 344,452 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-03+172,191→ 172,191 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-03+316,647→ 316,647 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (right to buy)
2024-07-16+30,000→ 30,000 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (right to buy)
2023-06-30+6,667→ 6,667 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (right to buy)
2022-06-24+40,000→ 40,000 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (right to buy)
2021-06-25+22,677→ 22,677 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (right to buy)
2020-12-22+6,825→ 6,825 total
Award
KINTERA INC
Stock Option (Right to Buy)
2004-07-29+200,000→ 200,000 total

Companies

Recent Filings

Address

1000 N. WEST STREET, SUITE 1200

WILMINGTON, DE, 19801

View on SEC.gov